{"id":299726,"date":"2026-10-09T17:23:25","date_gmt":"2026-10-09T11:53:25","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=299726"},"modified":"2026-10-09T17:23:25","modified_gmt":"2026-10-09T11:53:25","slug":"glaxosmithkline-pharmaceuticals-share-price-target-2027","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/glaxosmithkline-pharmaceuticals-share-price-target-2027\/","title":{"rendered":"GlaxoSmithKline Pharmaceuticals Share Price Target 2027: Base and Bull Targets Built on FY26 Earnings"},"content":{"rendered":"

GlaxoSmithKline Pharmaceuticals share price Rs 2,543.00 (9 October 2026). Base target Rs 3,042, bull Rs 3,643, downside risk Rs 2,028. PE 40.2. 52W range Rs 2,088.10 to Rs 3,120.70.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The GlaxoSmithKline Pharmaceuticals share price target for 2027 is Rs 3,042, about 19.6% above the current price of Rs 2,543.00. The bull case is Rs 3,643, and the downside risk level, which is not a target, is Rs 2,028. The base case assumes earnings per share grow 20.0% a year, a cap applied because the FY24 to FY26 pace was 32.5%, with the stock holding its PE of 40.2. These are model-based estimates built from reported financials, not guaranteed outcomes.<\/p>\n<\/p><\/div>\n

Investors weighing a GlaxoSmithKline Pharmaceuticals target price for 2027 should start with where the stock sits today. At Rs 2,543.00 on 9 October 2026, it is 18.5% below its 52-week high of Rs 3,120.70 and 21.8% above its 52-week low of Rs 2,088.10. That range spans 49% from low to high, so the entry point matters as much as the GlaxoSmithKline Pharmaceuticals price forecast itself.<\/p>\n

This article builds the GlaxoSmithKline Pharmaceuticals share price target from reported numbers only: five years of annual results, the last five quarters, the latest shareholding pattern and current valuation ratios from company filings and exchange data. Each scenario shows its assumptions, so you can see exactly how the Rs 3,042 base case and the Rs 3,643 bull case were reached, along with a downside risk level of Rs 2,028.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n